Literature DB >> 20680391

Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase.

Elisavet Serti1, Polyxeni P Doumba, George Thyphronitis, Panagiota Tsitoura, Konstantina Katsarou, Pelagia Foka, Manousos M Konstandoulakis, John Koskinas, Penelope Mavromara, Urania Georgopoulou.   

Abstract

Hepatitis C virus (HCV) has been shown to actively replicate in cells of the immune system, altering both their function and cytokine expression. Naked nucleocapsids have been reported in the serum of infected patients. We investigated interference of recombinant non-enveloped capsid-like particles with signaling pathways in T cells. HCV non-enveloped particles (HCVne) internalization was verified in Jurkat and Hut 78 T cells, as well as primary human peripheral blood and intrahepatic mononuclear cells. HCVne uptake leads to activation of the MAPKs-p38 signaling pathway. Using specific phosphoantibodies, signaling pathways inhibitors, and chemical agents, it was demonstrated that p38 activation in T cells correlated with IL-2 transcriptional activation and was accompanied by a parallel increase of IL-2 cytokine secretion. c-fos and egr-1, two transcription factors, essential for IL-2 promoter activity, were also found to be elevated. We propose that HCVne uptake by T lymphocytes results in increased MAPKs-p38 activity and IL-2 expression, thus altering the host immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680391     DOI: 10.1007/s00018-010-0466-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  90 in total

Review 1.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases.

Authors:  Sanjay Kumar; Jeffrey Boehm; John C Lee
Journal:  Nat Rev Drug Discov       Date:  2003-09       Impact factor: 84.694

2.  Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1/2 signaling events.

Authors:  Konstantina Katsarou; Alexandros Alpha Lavdas; Panagiota Tsitoura; Elisavet Serti; Panagiotis Markoulatos; Penelope Mavromara; Urania Georgopoulou
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

Review 3.  Hepatitis B or hepatitis C and human immunodeficiency virus infection.

Authors:  Robert Thimme; Hans Christian Spangenberg; Hubert E Blum
Journal:  J Hepatol       Date:  2005-01-28       Impact factor: 25.083

Review 4.  MAP kinases and the control of nuclear events.

Authors:  A G Turjanski; J P Vaqué; J S Gutkind
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

5.  MAP kinase p38 and its relation to T cell anergy and suppressor function of regulatory T cells.

Authors:  Henric S Adler; Kerstin Steinbrink
Journal:  Cell Cycle       Date:  2007-11-16       Impact factor: 4.534

6.  Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.

Authors:  K M Chang; R Thimme; J J Melpolder; D Oldach; J Pemberton; J Moorhead-Loudis; J G McHutchison; H J Alter; F V Chisari
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

7.  Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.

Authors:  Sampa Pal; Daniel G Sullivan; Sean Kim; K Kay-Yin Lai; John Kae; Scott J Cotler; Robert L Carithers; Brent L Wood; James D Perkins; David R Gretch
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

8.  Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.

Authors:  Shawn D Blackburn; Alison Crawford; Haina Shin; Antonio Polley; Gordon J Freeman; E John Wherry
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

9.  Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation.

Authors:  Kozo Ohkusu-Tsukada; Norio Tominaga; Heiichiro Udono; Katsuyuki Yui
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  MSK regulate TCR-induced CREB phosphorylation but not immediate early gene transcription.

Authors:  Madlen Kaiser; Giselle R Wiggin; Kurt Lightfoot; J Simon C Arthur; Andrew Macdonald
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

View more
  6 in total

1.  Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake.

Authors:  Polyxeni P Doumba; Elisavet Serti; Maria Boutsikou; Manousos M Konstadoulakis; Urania Georgopoulou; John Koskinas
Journal:  Cell Mol Life Sci       Date:  2013-05-05       Impact factor: 9.261

2.  Porcine reproductive and respiratory syndrome virus (PRRSV) up-regulates IL-8 expression through TAK-1/JNK/AP-1 pathways.

Authors:  Yihao Liu; Yinping Du; Honglei Wang; Li Du; Wen-Hai Feng
Journal:  Virology       Date:  2017-03-24       Impact factor: 3.616

3.  Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions.

Authors:  Polyxeni P Doumba; Marilena Nikolopoulou; Ilias P Gomatos; Manousos M Konstadoulakis; John Koskinas
Journal:  BMC Gastroenterol       Date:  2013-01-18       Impact factor: 3.067

4.  CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells.

Authors:  Cecilia Fernandez-Ponce; Margarita Dominguez-Villar; Enrique Aguado; Francisco Garcia-Cozar
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

Review 5.  Hepcidin and the iron enigma in HCV infection.

Authors:  Urania Georgopoulou; Alexios Dimitriadis; Pelagia Foka; Eirini Karamichali; Avgi Mamalaki
Journal:  Virulence       Date:  2014-03-13       Impact factor: 5.882

6.  Hepatitis C Virus Improves Human Tregs Suppressive Function and Promotes Their Recruitment to the Liver.

Authors:  Laurissa Ouaguia; Olivier Moralès; Lynda Aoudjehane; Czeslaw Wychowski; Abhishek Kumar; Jean Dubuisson; Yvon Calmus; Filomena Conti; Nadira Delhem
Journal:  Cells       Date:  2019-10-22       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.